Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine

Busulfan combined with cyclophosphamide (BuCy) has long been considered a standard myeloablative conditioning regimen for allogeneic hematopoietic cell transplantation (HCT), including both nonmalignant conditions and myeloid diseases. Substituting fludarabine for cyclophosphamide (BuFlu) to reduce...

Full description

Saved in:
Bibliographic Details
Published in:Blood Adv
Main Authors: Harris, Andrew C., Boelens, Jaap J., Ahn, Kwang Woo, Fei, Mingwei, Abraham, Allistair, Artz, Andrew, Dvorak, Christopher, Frangoul, Haydar, Freytes, Cesar, Gale, Robert Peter, Hong, Sanghee, Lazarus, Hillard M., Loren, Alison, Mineishi, Shin, Nishihori, Taiga, O’Brien, Tracey, Williams, Kirsten, Pasquini, Marcelo C., Levine, John E.
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2018
Subjects:
Transplantation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5998928/
https://ncbi.nlm.nih.gov/pubmed/29844205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018016956
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items